Immunoexpression of Ki67, P16 and Beta-catenin in precursor lesions of cutaneous squamous cell carcinoma
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.This study investigated biomarkers Ki67, P16, and Beta-catenin in skin cancer precursors. Higher levels in advanced lesions suggest their role in the progression of cutaneous squamous cell carcinoma (CSCC).
Area Of Science
- Dermatology
- Oncology
- Molecular Biology
Background
- Cutaneous squamous cell carcinoma (CSCC) is the second most prevalent skin cancer, with significant mortality risk upon metastasis.
- Actinic keratosis (AK) and Bowen's disease (BD) are recognized precursors to CSCC.
- Understanding molecular markers in precursor lesions is crucial for predicting CSCC progression.
Purpose Of The Study
- To analyze the expression of Ki67, P16, and Beta-catenin in CSCC precursor lesions.
- To correlate marker expression with histological prognostic parameters.
- To identify potential roles of these markers in CSCC prognosis.
Main Methods
- Immunohistochemical analysis of Ki67, P16, and Beta-catenin expression.
- Evaluation of precursor lesions including AK, keratinocyte intraepithelial neoplasia (KIN) III, and BD.
- Correlation analysis with histological prognostic factors.
Main Results
- Ki67 and P16 showed higher expression in advanced lesions (KIN III, BD) compared to less advanced ones (seborrheic keratosis).
- Immunoreactivity patterns support a multistage model of skin carcinogenesis.
- Linear correlations were found between P16, Ki67, and membranous Beta-catenin expression in AK.
Conclusions
- Ki67, P16, and Beta-catenin expression levels correlate with the stage of precancerous lesions.
- These markers are involved from the initiation phase of skin carcinogenesis.
- The study supports the prognostic significance of these markers in CSCC evolution.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
